Harima Y - Search Results

1

Bax and Bcl-2 protein expression following radiation therapy versus radiation plus thermoradiotherapy in stage IIIB cervical carcinoma.

Harima Y, Nagata K, Harima K, Oka A, Ostapenko VV, Shikata N, Ohnishi T, Tanaka Y. Harima Y, et al. Among authors: harima k. Cancer. 2000 Jan 1;88(1):132-8. Cancer. 2000. PMID: 10618615 Clinical Trial.

2

Transcatheter arterial embolization therapy in cases of recurrent and advanced gynecologic cancer.

Harima Y, Shiraishi T, Harima K, Sawada S, Tanaka Y. Harima Y, et al. Among authors: harima k. Cancer. 1989 May 15;63(10):2077-81. doi: 10.1002/1097-0142(19890515)63:10<2077::aid-cncr2820631034>3.0.co;2-8. Cancer. 1989. PMID: 2702578

3

Histopathological changes in rabbit uterus carcinoma after transcatheter arterial embolization using cisplatin.

Harima Y, Harima K, Hasegawa T, Shikata N, Tanaka Y. Harima Y, et al. Among authors: harima k. Cancer Chemother Pharmacol. 1996;38(4):317-22. doi: 10.1007/s002800050489. Cancer Chemother Pharmacol. 1996. PMID: 8674153

4

[Bax and Bcl-2 expression predict response to radiotherapy in human cervical cancer].

Harima Y, Oka A, Nagata K, Harima K, Tanaka Y, Shikata N. Harima Y, et al. Among authors: harima k. Gan To Kagaku Ryoho. 1998 Jul;25(9):1273-7. Gan To Kagaku Ryoho. 1998. PMID: 9703806 Japanese.

5

Bax and Bcl-2 expressions predict response to radiotherapy in human cervical cancer.

Harima Y, Harima K, Shikata N, Oka A, Ohnishi T, Tanaka Y. Harima Y, et al. Among authors: harima k. J Cancer Res Clin Oncol. 1998;124(9):503-10. doi: 10.1007/s004320050206. J Cancer Res Clin Oncol. 1998. PMID: 9808425

6

Genetic alterations on chromosome 17p associated with response to radiotherapy in bulky cervical cancer.

Harima Y, Shirahama S, Harima K, Aoki S, Ohnishi T, Tanaka Y. Harima Y, et al. Among authors: harima k. Br J Cancer. 1999 Sep;81(1):108-13. doi: 10.1038/sj.bjc.6690658. Br J Cancer. 1999. PMID: 10487620 Free PMC article.

7

Loss of heterozygosity on chromosome 6p21.2 as a potential marker for recurrence after radiotherapy of human cervical cancer.

Harima Y, Harima K, Sawada S, Tanaka Y, Arita S, Ohnishi T. Harima Y, et al. Among authors: harima k. Clin Cancer Res. 2000 Mar;6(3):1079-85. Clin Cancer Res. 2000. PMID: 10741737

8

Determination of p53-mediated transactivational ability in radiation-treated cervical cancer.

Oka A, Harima Y, Harima K, Ostapenko VV, Tanaka Y, Ohnishi T, Sawada S. Oka A, et al. Among authors: harima y, harima k. Cancer Detect Prev. 2000;24(3):275-82. Cancer Detect Prev. 2000. PMID: 10975290

9

A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma.

Harima Y, Nagata K, Harima K, Ostapenko VV, Tanaka Y, Sawada S. Harima Y, et al. Among authors: harima k. Int J Hyperthermia. 2001 Mar-Apr;17(2):97-105. doi: 10.1080/02656730010001333. Int J Hyperthermia. 2001. PMID: 11252361 Free article. Clinical Trial.

10

Chromosome 6p21.2, 18q21.2 and human papilloma virus (HPV) DNA can predict prognosis of cervical cancer after radiotherapy.

Harima Y, Sawada S, Nagata K, Sougawa M, Ohnishi T. Harima Y, et al. Int J Cancer. 2001 Oct 20;96(5):286-96. doi: 10.1002/ijc.1027. Int J Cancer. 2001. PMID: 11582581

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters